Transform Your Workflow and Empower Your Teams

Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development. 12/19. iBIO - Illinois Biotechnology Industry Organization · Capital Pulse ... 事件：公司公告，子公司香港健友及其控股子公司Meitheal拟与Xentria签署《许可协议》，Xentria授予健友在许可区域开发和商业化XTMAB的独占许可，并向 ... Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development ... The Growing Crisis of Antimicrobial Resistance: Meitheal ... In a significant ... ... Xentria. •. Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing Agreement for XTMAB-16 in North AmericaTullahoma News•Jun 27, 2023•Xentria, ... Prior to joining Xentria and Meitheal, Tom was Vice President of Global Alliance Management for Sagent Pharmaceuticals and was responsible for global ... NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business. Happenings. NKF and Meitheal Announce Dr. Jiali Luo as ... Xentria Entered into an Exclusive Multi-Year License Agreement with Meitheal to Commercialize XTMAB-16 for Pulmonary Sarcoidosis in North America. Shots:. In addition, Victoria is the General Counsel & Corporate Secretary of Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was ... Tom Shea is the founding President of Xentria and the founding CEO of Meitheal Pharmaceutical, Inc. ... Meitheal's General Counsel & Corporate Secretary since its inception in 2017. In addition, Victoria is the Corporate Secretary of Xentria, Inc. a biotech ...